Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
Journal of Personalized Medicine
|
March 6, 2021
Common Treatment, Common Variant: Evolutionary Prediction of Functional Pharmacogenomic Variants
Laura B Scheinfeldt, Andrew Brangan, Dara M Kusic, et al.
Pharmacogenetics and Genomics
|
December 19, 2018
Individuals with CYP2C8 and CYP2C9 reduced metabolism haplotypes self-adjusted ibuprofen dose in the Coriell Personalized Medicine Collaborative
Stefan C Zajic, Joseph P Jarvis, Pan Zhang, et al.
Public Health Genomics
|
April 21, 2025
Reporting Modifications from the IMPACT-FH Study using the FRAME-IS
Christie Gilbert Klaczko, Nicole L Walters, Andrew Brangan, et al.
American Journal of Preventive Cardiology
|
May 6, 2022
Patient experiences align with the familial hypercholesterolemia global call to action
Laney K Jones, Nicole Walters, Andrew Brangan, et al.
Journal of Genetic Counseling
|
August 6, 2025
User testing of a previsit chatbot developed for population genomic screening and counseling
Kelly M Morgan, Jessica Goehringer, Zoe Lindsey-Mills, et al.
Journal of Clinical Lipidology
|
September 15, 2024
Utilizing innovative implementation strategies for familial hypercholesterolemia: Implementation outcomes from the IMPACT-FH study
Gemme Campbell-Salome, Kelly M Morgan, Jazmine Gabriel, et al.
Journal of Personalized Medicine
|
July 2, 2021
Acceptability, Appropriateness, and Feasibility of Automated Screening Approaches and Family Communication Methods for Identification of Familial Hypercholesterolemia: Stakeholder Engagement Results from the IMPACT-FH Study
Laney K Jones, Nicole Walters, Andrew Brangan, et al.
Diabetes Spectrum : a Publication of the American Diabetes Association
|
January 12, 2026
Population Screening for Type 1 Diabetes in Pediatrics via Well-Child Visits: Barriers and Facilitators to Implementation
Christie Gilbert Klaczko, Nicole Walters, Alexis E Blackburn, et al.
BMC Medical Genomics
|
January 8, 2021
The Genomics of Opioid Addiction Longitudinal Study (GOALS): study design for a prospective evaluation of genetic and non-genetic factors for development of and recovery from opioid use disorder
Jessica Heil, Stefan Zajic, Emily Albertson, et al.
PEC Innovation
|
May 22, 2023
Facilitating family communication of familial hypercholesterolemia genetic risk: Assessing engagement with innovative chatbot technology from the IMPACT-FH study
Nicole L Walters, Zoe T Lindsey-Mills, Andrew Brangan, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
Journal of Personalized Medicine
|
March 6, 2021
Common Treatment, Common Variant: Evolutionary Prediction of Functional Pharmacogenomic Variants
Laura B Scheinfeldt, Andrew Brangan, Dara M Kusic, et al.
Pharmacogenetics and Genomics
|
December 19, 2018
Individuals with CYP2C8 and CYP2C9 reduced metabolism haplotypes self-adjusted ibuprofen dose in the Coriell Personalized Medicine Collaborative
Stefan C Zajic, Joseph P Jarvis, Pan Zhang, et al.
Public Health Genomics
|
April 21, 2025
Reporting Modifications from the IMPACT-FH Study using the FRAME-IS
Christie Gilbert Klaczko, Nicole L Walters, Andrew Brangan, et al.
American Journal of Preventive Cardiology
|
May 6, 2022
Patient experiences align with the familial hypercholesterolemia global call to action
Laney K Jones, Nicole Walters, Andrew Brangan, et al.
Journal of Genetic Counseling
|
August 6, 2025
User testing of a previsit chatbot developed for population genomic screening and counseling
Kelly M Morgan, Jessica Goehringer, Zoe Lindsey-Mills, et al.
Journal of Clinical Lipidology
|
September 15, 2024
Utilizing innovative implementation strategies for familial hypercholesterolemia: Implementation outcomes from the IMPACT-FH study
Gemme Campbell-Salome, Kelly M Morgan, Jazmine Gabriel, et al.
Journal of Personalized Medicine
|
July 2, 2021
Acceptability, Appropriateness, and Feasibility of Automated Screening Approaches and Family Communication Methods for Identification of Familial Hypercholesterolemia: Stakeholder Engagement Results from the IMPACT-FH Study
Laney K Jones, Nicole Walters, Andrew Brangan, et al.
Diabetes Spectrum : a Publication of the American Diabetes Association
|
January 12, 2026
Population Screening for Type 1 Diabetes in Pediatrics via Well-Child Visits: Barriers and Facilitators to Implementation
Christie Gilbert Klaczko, Nicole Walters, Alexis E Blackburn, et al.
BMC Medical Genomics
|
January 8, 2021
The Genomics of Opioid Addiction Longitudinal Study (GOALS): study design for a prospective evaluation of genetic and non-genetic factors for development of and recovery from opioid use disorder
Jessica Heil, Stefan Zajic, Emily Albertson, et al.
PEC Innovation
|
May 22, 2023
Facilitating family communication of familial hypercholesterolemia genetic risk: Assessing engagement with innovative chatbot technology from the IMPACT-FH study
Nicole L Walters, Zoe T Lindsey-Mills, Andrew Brangan, et al.
Page
of 2